Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.
Living with chronic knee pain from osteoarthritis can significantly impact your quality of life, making everyday activities a challenge. While various treatments exist, two options often discussed are hyaluronic acid injections and the more recent approach of adipose-derived stem cell therapy. Understanding the fundamental differences between them is crucial for anyone exploring ways to manage their knee pain.
This article provides a comparison of these two distinct approaches. Hyaluronic acid is a well-established method for temporary symptom relief, while adipose-derived stem cell therapy represents a regenerative medicine strategy that aims to address the underlying cellular environment. The best path forward is a personal decision that should always be made after a thorough consultation with a physician.
Hyaluronic Acid Injections: A Closer Look at a Common Treatment
Hyaluronic acid is a substance that occurs naturally in the synovial fluid of our joints, where it acts as a lubricant and shock absorber. In individuals with osteoarthritis, the concentration and quality of this fluid can decrease, leading to increased friction, pain, and stiffness.
Hyaluronic acid injections, sometimes called viscosupplementation, involve injecting a gel-like solution directly into the knee joint. The goal is to supplement the joint’s natural fluid, potentially reducing pain and improving function. This treatment is a local therapy, meaning it only affects the joint into which it is injected. The effects are generally temporary, and many patients require a series of injections, often repeated every few months to maintain any benefits.
Adipose-Derived Stem Cell Therapy: A Regenerative Approach
Adipose-derived stem cell therapy is a form of regenerative medicine that utilizes your body’s own cells. The treatment involves collecting a small amount of fat tissue (adipose tissue), from which mesenchymal stem cells (MSCs) are isolated. These cells are then cultured and expanded in a specialized facility before being returned to your body, typically through an intravenous (IV) infusion.
Unlike hyaluronic acid, which provides mechanical lubrication, MSCs are thought to work on a biological level. Research suggests they may have several actions:
- Modulating Inflammation: MSCs have been reported to secrete substances that can help calm chronic inflammation within the joint environment.
- Supporting Tissue Repair: They may release growth factors that encourage the body’s own repair processes.
- Immune System Regulation: MSCs are also studied for their potential to help balance immune responses that contribute to tissue damage.
A key difference is the method of administration. At our clinic, the cultured stem cells are administered via an IV drip. Infused MSCs have been reported to travel through the bloodstream and accumulate at sites of inflammation or damage, an effect known as “homing.” This means the approach is systemic, potentially influencing the body’s overall inflammatory state, not just a single joint.
Key Differences: Mechanism, Protocol, and Scope
When comparing these two options, it’s helpful to focus on three main areas:
1. Mechanism of Action: Hyaluronic acid provides symptomatic relief by acting as a lubricant. Adipose-derived stem cell therapy aims to modulate the underlying biological environment by reducing inflammation and supporting the body’s innate repair mechanisms.
2. Treatment Protocol: Hyaluronic acid involves a relatively quick injection into the knee, often repeated in a series over weeks or months. Stem cell therapy is a more involved process, including fat collection, a cell culturing period that takes several weeks, and a final IV infusion. The therapeutic effects are evaluated over a longer timeframe and are not immediate.
3. Scope of Treatment: Hyaluronic acid is a local treatment for a specific joint. Systemic IV administration of stem cells has the potential to reach multiple areas of inflammation in the body, offering a whole-body approach to managing chronic inflammatory conditions.
Important Considerations for Regenerative Medicine in Japan
If you are considering adipose-derived stem cell therapy, it is essential to understand the context in which it is provided in Japan. This treatment is a form of private medical care and is not covered by Japanese public health insurance. The full cost is borne by the patient.
Furthermore, regenerative medicine is regulated under Japan’s Act on the Safety of Regenerative Medicine. This ensures that treatments are provided according to a plan submitted to and accepted by the Ministry of Health, Labour and Welfare, which includes strict standards for cell processing and safety management.
It is crucial to have realistic expectations. Outcomes can vary between individuals, and this therapy is not a guaranteed cure for osteoarthritis. A physician must determine if you are a suitable candidate based on your overall health, medical history, and the severity of your condition. All potential benefits, risks, side effects, and costs must be discussed in detail during a medical consultation.
Making an Informed Decision for Your Knee Health
Choosing a treatment for knee osteoarthritis is a significant decision. While hyaluronic acid injections offer a well-established option for temporary, local symptom management, adipose-derived stem cell therapy provides a different, systemic approach focused on modulating the body’s inflammatory and repair processes. It represents an option for those seeking to invest in their long-term health beyond conventional symptom relief.
The first step is always a comprehensive discussion with a qualified physician. At Grand Green Osaka Umekita Clinic, we are committed to helping patients understand all their options. If you are in the Osaka area and wish to explore whether regenerative medicine is appropriate for you, we encourage you to learn more about our approach.
For more detailed information on our adipose-derived stem cell therapy, including the treatment flow and frequently asked questions, please visit our information page. A consultation with our medical team can provide personalized insights into your specific condition and help you decide on the most suitable path for your health goals.
Learn more about Adipose-Derived Stem Cell Therapy at our clinic.
Hyaluronic Acid
- Acts as a lubricant
- Local treatment for one joint
- Temporary symptom relief
Stem Cells
- Modulates biological environment
- Systemic, whole-body approach
- Calms inflammation, aids repair
This is a conceptual diagram to summarize the article's content
References
- PMC: The role of adipose-derived mesenchymal stem cells in knee osteoarthritis: a meta-analysis of randomized controlled trials. (2022)
- PMC: Therapeutic efficacy of intra-articular injection of human adipose-derived mesenchymal stem cells in a sheep model of knee osteoarthritis. (2025)
- PMC: Allogeneic adipose-derived mesenchymal stem cells promote the expression of chondrocyte redifferentiation markers and retard the progression of knee osteoarthritis in rabbits. (2021)
- PMC: Intra-Articular Injection of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Phase IIb, Randomized, Placebo-Controlled Clinical Trial. (2019)
- MHLW (Japan): Regenerative Medicine — Ministry of Health, Labour and Welfare, Japan
Supervising Physician
Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic
Hidenori Shimada
Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.
* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.